NTEC News and Press, Intec Pharma Ltd. From 01/02/19

JERUSALEM , Jan. 2, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces the dosing of the first patient in a Phase 1 pharmacokinetic (PK) study of AP-THC, its proprietary Accordion Pill™ platform containing synthetic tetrahydrocanna...

NEW YORK, NY / ACCESSWIRE / December 3, 2018 / There was no news to explain the new high that Intec Pharma hit on Friday but Oragenics surged over 30% after announcing the publication of a research paper last week. The Market Edge Initiates Coverage on: Oragenics, Inc. https://market...

JERUSALEM , Nov. 6, 2018 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences in November.  H.C. Wainwright 2018 Annual Israel Conference Date: ...

NEW YORK, NY / ACCESSWIRE / September 20, 2018 / GW Pharmaceuticals hit a brand new high yesterday after a report revealed that the FDA is planning to reclassify the company’s Epidiolex to be allowed for medicinal use. Shares of Intec Pharma also saw gains despite a catalyst. RDI In...

JERUSALEM , Sept. 20, 2018 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences.  Oppenheimer 2018 Fall Summit - Focused on Specialty Pharma and Ra...

JERUSALEM , Aug. 15, 2018 /PRNewswire/ --   Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the three and six months ended June 30, 2018 and provides a corporate update.  Highlights of the second quarter 2018 and recent wee...

Over the past couple of decades our most profitable sector has been biotech stocks. We use a process that has been refined over the years. The analysis is complex and time consuming, but worth the effort, asserts small cap expert Bill Mathews , editor of The Cheap Investor . We evaluat...

A recent study from Cowen Research says that biotech investors shouldn’t count on sell-side analysts’ ratings of stocks in the sector. In fact, biotech investors should do the exact opposite of their recommendations, and buy when analysts say sell, and vice versa. According to ...

JERUSALEM , June 29, 2018 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC) ("Intec" or "the Company") today announces the appointment of William Bradley Hayes (Brad) to the Company's Board of Directors.  Mr. Hayes was formerly Executive Vice President, Chief Financia...

Shares of Intec Pharma ( NTEC ) rose by over 50% shortly after I suggested readers pull the trigger after the secondary offering last August- from there the stock lost all signs of strength and is currently 22% in the red and trading near all-time lows. Chart Figure 1: NTEC daily a...